AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLIPIZIDE
8 registrations across 6 African markets— 5 active
Markets with GLIPIZIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Betaglip Tablets Tablet | 🇳🇬Nigeria | Swiss Pharma Nigeria Limited | active | Dec 2026 |
| NOVOGLIP_5 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| MINIDIAB | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Oct 2022 |
| SUCRAZIDE Comprimé sécable / 5 MG | 🇹🇳Tunisia | Dar Al Dawa Development and Investment Co.Ltd | expired | Mar 1993 |
| MINIDIAB COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
| GLIPIZIDE | 🇺🇬Uganda | ABACUS PHARMA (AFRICA) LIMITED | active | — |
| GLIPIZIDE | 🇺🇬Uganda | ABACUS PHARMA (AFRICA) LIMITED | active | — |
| MINIDIAB COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
GLIPIZIDE in Africa — Regulatory Overview
GLIPIZIDE is registered across 6 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Uganda, Malawi, Nigeria and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.